Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Orvosi Hetilap|September 24, 1998
[A new radiation-free conditioning in bone marrow transplantation and dibromo-mannitol therapy in chronic myeloid leukemia]E Kelemen, R Dénes, A Barta, et al.
Acta Haematologica|June 16, 2001
Remarkably reduced transplant-related complications by dibromomannitol non-myeloablative conditioning before allogeneic bone marrow transplantation in chronic myeloid leukemiaA Barta, R Dénes, T Masszi, et al.
Bone Marrow Transplantation|October 12, 1999
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow TransplantationG Gahrton, H Svensson, B Björkstrand, et al.
Leukemia|February 21, 2017
Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom studyA Hochhaus, T Masszi, F J Giles, et al.
Leukemia|October 7, 2015
Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st studyA Hochhaus, G Rosti, N C P Cross, et al.
Bone Marrow Transplantation|September 22, 2019
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)E González-Barca, A Boumendil, D Blaise, et al.
Bone Marrow Transplantation|March 24, 2015
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)M Mohty, F Malard, M Abecassis, et al.
Bone Marrow Transplantation|May 17, 2016
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow TransplantationM Mohty, F Malard, M Abecassis, et al.
Leukemia|July 16, 2016
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)R Hájek, T Masszi, M T Petrucci, et al.
Pageof 3